about
Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments.Features of GBA-associated Parkinson's disease at presentation in the UK Tracking Parkinson's study.Heterozygous carriers of galactocerebrosidase mutations that cause Krabbe disease have impaired microglial function and defective repair of myelin damage.Emerging Disease-Modifying Strategies Targeting α-Synuclein for the Treatment of Parkinson Disease.Integrated Genetic Analysis of Racial Differences of Common GBA Variants in Parkinson's Disease: A Meta-Analysis.Centrality of Early Synaptopathy in Parkinson's Disease.Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders.A Meta-Analysis of -Related Clinical Symptoms in Parkinson's DiseaseReduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease
P2860
Q45873810-929D676D-D6F6-4C07-8761-27F0D9D096DEQ47552228-8C118F78-0E5B-4665-96D2-E46533152471Q52330247-262F9622-AE33-46DF-91A3-064429A9882AQ52714245-0E5ACC1C-B8F9-481A-A26C-394894EB7AA5Q55056377-09702C77-3F46-492A-9ABA-9DD61C5CCB5AQ55071517-B7DAD665-D616-4053-91DB-190E6F194C9EQ55122433-57076814-B6AC-4E3D-BC0E-397C78234425Q58549914-F5B5E86E-4070-4463-A20B-3060CFB25F0DQ58603525-A2E15094-83EE-4754-A3DD-78BB6ED8F269
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Glucocerebrosidase Mutations in Parkinson Disease.
@en
Glucocerebrosidase Mutations in Parkinson Disease.
@nl
type
label
Glucocerebrosidase Mutations in Parkinson Disease.
@en
Glucocerebrosidase Mutations in Parkinson Disease.
@nl
prefLabel
Glucocerebrosidase Mutations in Parkinson Disease.
@en
Glucocerebrosidase Mutations in Parkinson Disease.
@nl
P2093
P2860
P356
P1476
Glucocerebrosidase Mutations in Parkinson Disease.
@en
P2093
Grace O'Regan
Roberta Balestrino
Ruth-Mary deSouza
P2860
P304
P356
10.3233/JPD-171092
P577
2017-06-07T00:00:00Z